CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
BridgeBio Pharma
BridgeBio Pharma logo

BridgeBio Pharma

Bridgebio Pharma, a US-based biotech firm, specializes in developing medicines for genetic diseases globally.

Palo Alto, CA, US🇺🇸
Founded
2015
Overview
M & A
Compare
Fundraising
Employees
Library

BridgeBio Pharma, based in Palo Alto, focuses on developing transformative medicines for genetic diseases and cancers with clear genetic drivers. The company aims to merge finance and science to expedite drug development, providing innovative solutions to patients worldwide. Their platform emphasizes rapid scientific discovery and development, ensuring that breakthroughs quickly translate into patient treatments.

BridgeBio Pharma has made significant strides in the biotech industry, with a robust pipeline of potential therapies targeting various genetic conditions. Their rigorous approach to science and commitment to patient outcomes have positioned them as a key player in the field. The company's impact is evident in its ongoing efforts to bring new, effective treatments to market, improving the lives of patients globally.

BridgeBio Pharma - M & A Snapshot

Open M & A

  • QED Therapeutics

    Acquired by BridgeBio Pharma • Undisclosed

BridgeBio Pharma - Quick Facts

Who are BridgeBio Pharma's competitors?

Companies similar to BridgeBio Pharma include Cogent Biosciences, Kyntra Bio, BridGene Biosciences and Generation Bio.

When was BridgeBio Pharma founded?

BridgeBio Pharma was founded in 2015.

Where is BridgeBio Pharma's headquarters located?

BridgeBio Pharma's headquarters is located in Palo Alto, CA, US.

When was BridgeBio Pharma's last funding round?

BridgeBio Pharma's most recent funding round was for $1.3B (USD) in January 2024.

How much disclosed funding has BridgeBio Pharma raised?

As of Jan 18, 2024, BridgeBio Pharma has disclosed funding of $3.6B (USD). Undisclosed round amounts are excluded.

How many employees does BridgeBio Pharma have?

BridgeBio Pharma has 392 employees as of Feb 6, 2024.

BridgeBio Pharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Genetic Medicines
Tags
  • Healthtech
Ticker
  • BBIO
SEC CIK
  • 0001743881
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations

BridgeBio Pharma - Similar Companies

GondolaBio logo

GondolaBio

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

BridGene Biosciences logo

BridGene Biosciences

Generation Bio logo

Generation Bio

generationbio.com

Benitec Biopharma logo

Benitec Biopharma

benitec.com

Apic Bio logo

Apic Bio

Denovo Biopharma logo

Denovo Biopharma

Sangamo Therapeutics logo

Sangamo Therapeutics

sangamo.com

MacroGenics logo

MacroGenics

macrogenics.com

Seven Bridges logo

Seven Bridges

sevenbridges.com

Precision BioSciences logo

Precision BioSciences

Bridge Medicines logo

Bridge Medicines

Regenxbio logo

Regenxbio

regenxbio.com

Blueprint Medicines logo

Blueprint Medicines

StrideBio logo

StrideBio

stridebio.com

ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research